Quantcast
Last updated on April 19, 2014 at 8:45 EDT

Latest Sage Bionetworks Stories

2013-11-11 08:28:02

Competition to develop more efficient treatment strategies for breast cancer patients awards six leading teams cash prizes MARINA DEL REY, Calif., Nov. 11, 2013 /PRNewswire/ -- Heritage Provider Network, (HPN) The National Cancer Institute, (NCI) Sage Bionetworks and DREAM announced the best performers in the Heritage-DREAM Breast Cancer Network Inference Challenge. The competition challenged teams to use big data to develop more effective treatments for breast cancer. Six best...

2013-11-07 08:33:36

Challenge to be first in a series to crowdsource Alzheimer's data for new disease insights WASHINGTON, Nov. 7, 2013 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease, Sage Bionetworks, and IBM's DREAM, today announced the Alzheimer's Disease Big Data (AD#1) Challenge at the Alzheimer's Disease Summit: The Path to 2025. The Summit, hosted by CEOi and the New York Academy of Sciences, is convening key industry, academic, government, and patient...

2013-04-19 16:23:26

Competition aims to develop more efficient treatment strategies for breast cancer patients SAN FRANCISCO, April 19, 2013 /PRNewswire/ -- Heritage Provider Network (HPN), The National Cancer Institute, Sage Bionetworks and DREAM today announced the Heritage-DREAM Breast Cancer Network Inference Challenge. The prize contest uses big data to develop more effective treatments for breast cancer, and was featured at the Sage Bionetworks Commons Congress in San Francisco, California....

2012-12-19 08:25:24

CAMBRIDGE, Mass., Dec. 19, 2012 /PRNewswire/ -- H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of oncology treatments, announced today that it has forged a partnership with Sage Bionetworks to jointly develop software platforms that advance critical components of H3's cancer genomics research. Sage will pair its advanced predictive modeling capabilities and collaboration platform with H3's assimilation of genomic and pharmacology data to...